Jefferson Capital (JCAP) delivered its strongest growth quarter of the year. Adjusted EPS of $0.83 beat the $0.70 consensus by 13.7% and cleared the $0.73 Earnings Whisper number. Revenue of $185.5 million topped the $173.4 million estimate by 7.0%. The more important story is acceleration. Revenue grew 23.0% year over year, after roughly 14% in the first quarter and 16% in the second. Collections jumped 35% to a record $319.2 million, up from about 18%-19% growth in the first half. Deployments more than doubled to a record $318.0 million, with triple-digit gains in the U.S., U.K., and Latin America. Estimated remaining collections (ERC) broke out of a three-quarter plateau near $3.4 billion and reached $3.6 billion. Earnings growth of 12.2% trailed revenue growth, and that gap is where the scrutiny belongs.

The quality of the beat is good but not pristine. GAAP EPS rose to $0.76 from $0.59, and GAAP pre-tax income climbed to $58.9 million from $45.5 million. Adjusted net income, however, grew only 7.5% to $51.3 million. Several factors flattered the quarter:

• **Bluestem:** The portfolio purchase, closed in the fourth quarter of 2025, supplied $32.2 million of U.S. collections, $13.4 million of portfolio revenue, and $10.3 million of net operating income.
• **Recoveries:** Changes in recoveries contributed $7.2 million, versus just $0.5 million a year earlier.
• **Tax:** Management acknowledged that the third-quarter tax rate benefited from catch-up items and guided to a mid-20s rate going forward.

The adjusted figures are not aggressive, however. They strip out a $4.0 million foreign-exchange gain, and the adjusted share count includes 4.1 million unvested restricted shares. Cost discipline also improved. Operating expenses grew 22.7% against 35% collections growth, compared with 46% opex growth in the second quarter. The cash efficiency ratio edged up to 72.9%.

The call preserved a credible growth story and broadened it. Auto finance has moved from something management was "watching closely" earlier in the year to a third performing-portfolio asset class, alongside credit cards and installment loans. Management framed consumer stress in auto, including high payments and negative equity, as a supply tailwind. Other strategic steps included:

• a second Mexico purchase following the market entry announced last quarter;
• the tuck-in acquisition of FIN Solutions, a bankruptcy-data business bought at 4.6 times trailing earnings;
• a $100 million reopening of the 2030 notes at 104, which leaves no debt maturities until 2029.

The company does not give formal guidance, so this was an improvement in reported fundamentals rather than a raised outlook. Management's tone was noticeably more confident.

Bears still have legitimate ammunition, and it sits in the forward indicators:

• **Forward flows:** Total commitments fell to $384 million from a record $480.7 million in the second quarter. Next-12-month contracted flows slipped to $267.5 million from $312 million. Management attributed the decline to renewal timing, and commitments remain roughly 20% higher year over year.
• **Replacement need:** The deployment required to replace runoff rose to $642 million from $565 million, because the performing mix carries lower purchase price multiples.
• **Auto visibility:** Auto deals are largely static-pool and lumpy, which limits visibility into future quarters.
• **Bluestem runoff:** Bluestem ERC has fallen to $186 million from $296 million at year-end. Management indicated the headline efficiency ratio should drift back toward roughly 68% without new performing purchases.
• **Leverage and returns:** Leverage rose to 1.73x from 1.59x a year ago, though it was essentially flat sequentially. Adjusted pre-tax ROE dipped to 50.9% from 51.6%.

That is the central tension. The third quarter proved JCAP can deploy aggressively, but sustaining this pace requires continually sourcing lumpy, lower-multiple deals.

The market had grown skeptical before the print. Shares closed at $19.94 on the eve of the report, down 13.5% from the $23.05 open after the August release. They have given back much of the run to a 52-week high of $24.44 set just days after that report. The stock sat almost exactly on its 200-day moving average of $19.92 and about 6% above its October low of $18.76. Investor sentiment remained positive but cooled, falling from 0.317 to 0.224. The Earnings Whispers trend readings are mixed: momentum is positive, while AVWAP remains negative. In short, expectations were modest heading into a quarter that clearly exceeded them.

The bottom line is that Jefferson Capital posted a decisive beat built on genuine reacceleration in collections, revenue, ERC, and deployments, with improving operating leverage and a widening opportunity set in auto, Mexico, and bankruptcy. The softer forward-flow book, rising replacement needs, Bluestem runoff, and a tax-aided quarter mean the next leg depends on continued deal flow rather than locked-in visibility. With the stock parked at its 200-day average and sentiment subdued, the report challenges the pessimism, but the forward indicators will determine whether that holds.